Nanoparticles in Clinical Translation for Cancer Therapy.

Int J Mol Sci

Department of Clinical Oncology, Queen Elizabeth Hospital, Kowloon, Hong Kong, China.

Published: February 2022

The advent of cancer therapeutics brought a paradigm shift from conventional therapy to precision medicine. The new therapeutic modalities accomplished through the properties of nanomaterials have extended their scope in cancer therapy beyond conventional drug delivery. Nanoparticles can be channeled in cancer therapy to encapsulate active pharmaceutical ingredients and deliver them to the tumor site in a more efficient manner. This review enumerates various types of nanoparticles that have entered clinical trials for cancer treatment. The obstacles in the journey of nanodrug from clinic to market are reviewed. Furthermore, the latest developments in using nanoparticles in cancer therapy are also highlighted.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835852PMC
http://dx.doi.org/10.3390/ijms23031685DOI Listing

Publication Analysis

Top Keywords

cancer therapy
16
cancer
6
therapy
5
nanoparticles
4
nanoparticles clinical
4
clinical translation
4
translation cancer
4
therapy advent
4
advent cancer
4
cancer therapeutics
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!